Positron Corp

Company: Positron Corp
Product: “POSICAM HZ,” “POSICAM HZL,” “mPower PET” and other Positron Emission Tomography diagnostic scanners
Date: 4/26/04

The above-referenced service reports indicated that an upgrade was needed. There are no records attached or referenced in these service reports or clear descriptions to explain if the upgrade was due to a hardware design problem, a software design problem or other recurring quality problems.

You terminated an employee who handled your firm’s customer complaint handling but failed to hire new employees or reassign existing employees to maintain your firm’s complaint files. An electronic customer service database was created to document customer complaints, but it was never implemented [FDA-483 Item 6].

An electronic customer service database was not implemented to document and evaluate customer complaints as required by your firm’s Complaint Handling Procedure (P.O.S. 4.14.03). This deviation was not detected by either management reviews or internal audits.

Failure to maintain complaint files for receiving, reviewing, and evaluating complaints by a formally designated unit [21 CFR 820.198(a)] [FDA-483 Item 61, a similar deviation from the previous inspection in 11/2001. For example, one of your firm’s employees created a customer service database in order to document all complaints electronically, however, your firm never implemented this database.

Failure to calibrate measuring and test equipment, including mechanical, automated, or electronic inspection and test equipment, to ensure that they are capable of producing valid results [21 CFR 820.72(a)] [FDA-483 Item 9]. For example, all the equipment listed in your firm’s Master Calibration List had not been calibrated by their due date in 2004. Your firm stated to our investigator that since your firm was not manufacturing at the time of the inspection, your firm was not required to calibrate the listed measuring equipment. Your firm’s rationale is not acceptable since these measuring equipment can be used to verify the results produced during either in-house repairs of electronic/assembly components, design changes or when your firm begins to manufacture new device units.

FDA District: Dallas District Office

About the author

Amy enjoys researching and writing about developments in medical technology and how that intersects with US law. She received her J.D. from the University of Florida Levin College of Law in 2020 and now works as a Regulatory Associate for SoftwareCPR®, a general-purpose regulatory consulting firm that is recognized globally for their expertise with standards and national regulations pertaining to medical device, mobile medical app, and HealthIT software.

SoftwareCPR Training Courses:

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Being Agile & Yet Compliant (Public or Private)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for scheduling!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

2-days onsite (4 days virtual) with group exercises, quizzes, examples, Q&A.

Instructors: Mike Russell, Ron Baerg

Next public offering: March 7 & 28, 2024

Virtual via Zoom

Registration Link:

Register Now

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.